IM Cannabis (IMCC) Interest Coverage Ratio (2020 - 2026)
IM Cannabis' (IMCC) quarterly Interest Coverage Ratio came in at 1.36 in Q1 2026, down 532.54% year-on-year from 0.31 in Q1 2025, and up 63.03% quarter-over-quarter from 3.67 in Q4 2025.
IM Cannabis (IMCC) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
IM Cannabis' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 1.36 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 532.54% year-over-year to 1.36 in Q1 2026; TTM through Mar 2026 was 4.46, a 157.46% decrease from a year earlier, with the FY2025 full-year figure at 3.31, down 54.25% from the prior year.
- Interest Coverage Ratio climbed to 1.36 in Q1 2026 per IMCC's latest filing, from 3.67 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 869.14 in Q4 2023 and bottomed at 19.05 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 0.31 (2025), against an average of 50.92.
- Across the five-year window, Interest Coverage Ratio jumped 18421.48% in 2023 and slumped 532.54% in 2026, its largest moves.
- Year by year, Interest Coverage Ratio stood at 4.69 in 2022, then soared by 18421.48% to 869.14 in 2023, then plunged by 98.86% to 9.92 in 2024, then tumbled by 136.96% to 3.67 in 2025, then surged by 63.03% to 1.36 in 2026.
- Per Business Quant, the three latest IMCC Interest Coverage Ratio figures stand at 1.36 (Q1 2026), 3.67 (Q4 2025), and 5.67 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -1.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.36 |
| Dec 31, 2025 | -3.67 |
| Sep 30, 2025 | -5.67 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 9.92 |
| Sep 30, 2024 | 6.94 |
| Jun 30, 2024 | 2.37 |
| Mar 31, 2024 | -14.04 |
| Dec 31, 2023 | 869.14 |
| Sep 30, 2023 | -0.56 |
| Jun 30, 2023 | 4.88 |
| Mar 31, 2023 | 5.70 |
| Dec 31, 2022 | 4.69 |
| Sep 30, 2022 | -19.05 |
| Jun 30, 2022 | 7.20 |
| Mar 31, 2022 | -1.26 |
| Dec 31, 2021 | -53.81 |
| Sep 30, 2021 | -15.84 |
| Jun 30, 2021 | 24.12 |